defect
dna
recombin
due
mutat
result
combin
immunodefici
cid
rang
diseas
sever
present
clinic
immunolog
molecular
characterist
patient
defect
account
combin
immun
defici
case
kuwait
nation
primari
immunodefici
disord
registri
distribut
patient
follow
defici
defici
defici
nine
patient
present
scid
os
leaki
scid
cid
granuloma
andor
autoimmun
cidgai
eight
patient
scid
os
receiv
hematopoiet
stem
cell
transplant
hsct
median
age
hsct
month
median
time
diagnosi
hsct
month
fifti
percent
transplant
patient
aliv
untranspl
one
aliv
combin
immunodefici
diseas
cid
compris
heterogen
group
genet
condit
character
profound
defici
cell
type
b
cell
nk
cell
number
function
typic
atyp
form
sever
combin
immun
defici
scid
repres
sever
form
cid
base
newborn
screen
nb
result
eleven
unit
state
america
usa
typic
atyp
scid
found
affect
newborn
howev
recent
studi
kuwait
show
estim
occurr
live
birth
attribut
high
rate
consanguin
marriag
v
j
recombin
crucial
assembl
express
b
lymphocyt
antigen
receptor
promot
differenti
b
lymphocyt
v
j
recombin
initi
bind
recombinationactiv
gene
product
recombin
signal
sequenc
rsss
flank
variabl
v
divers
join
j
code
element
b
cell
receptor
bcr
cell
receptor
tcr
gene
induc
dna
doubl
strand
break
leav
hairpin
structur
code
end
upon
phosphoryl
dna
protein
kinas
catalyt
subunit
dnapkc
complex
artemi
encod
gene
recruit
mediat
hairpin
open
via
endonucleas
activ
join
code
end
well
excis
signal
end
accomplish
protein
nonhomolog
endjoin
pathway
accordingli
null
mutat
affect
develop
b
lymphocyt
caus
b
scid
howev
hypomorph
mutat
gene
may
caus
milder
phenotyp
studi
present
clinic
immunolog
molecular
characterist
consecut
patient
kuwait
present
rag
gene
defect
year
patient
data
retriev
kuwait
nation
primari
immunodefici
disord
registri
knpidr
prospect
recruit
patient
sinc
project
approv
research
ethic
committe
ministri
health
kuwait
genom
dna
extract
whole
blood
sanger
dna
sequenc
perform
accord
standard
protocol
target
nextgener
sequenc
perform
use
pid
panel
ion
torrent
sequenc
thermofish
averag
coverag
variant
call
perform
use
ion
report
softwar
thermofish
whole
exom
sequenc
exom
captur
ta
clini
ever
e
aven
w
perform
use
sureselect
human
exon
utr
kit
agil
technolog
hiseq
system
illumina
use
gener
basepair
pairedend
read
averag
ontarget
coverag
read
align
refer
assembl
human
genom
use
bwa
singl
nucleotid
variant
indel
detect
gatk
use
standard
hard
filter
paramet
variant
read
coverag
phredscal
snp
qualiti
elimin
whole
genom
sequenc
read
map
local
de
novo
assembl
variant
call
annot
perform
complet
genom
inc
peripher
venou
blood
drawn
use
tube
contain
edta
blood
sampl
process
within
two
hour
collect
test
tube
prepar
blood
cytostat
tetra
chrome
cytostst
tetra
chrome
murin
monoclon
antibodi
mixtur
beckman
coulter
usa
ad
antibodi
mixtur
allow
simultan
identif
quantif
total
lymphocyt
subpopul
express
cell
sampl
incub
dark
room
temperatur
min
incub
stabil
fixat
stain
cell
perform
ad
immunoprep
kit
reagent
beckman
coulter
usa
analysi
lymphocyt
subset
perform
epic
xlmcl
flow
cytomet
mw
beckman
coulter
electron
fl
equip
argon
ion
laser
tune
wavelength
nm
valu
lymphocyt
subpopul
determin
percentag
mononuclear
cell
absolut
valu
lymphocyt
subset
count
per
determin
via
addit
flow
count
fluorospher
beckman
coulter
usa
perform
fluoresc
gate
strategi
use
vs
side
scatter
intern
qualiti
assur
perform
use
optic
align
bead
compens
reagent
use
elimin
bleed
fluoresc
immunotrol
control
cell
data
analysi
perform
coulter
tetraon
system
softwar
system
ii
softwar
peripher
blood
obtain
subject
venipunctur
pbmc
separ
ficollpaqu
pharmacia
biotech
sweden
densiti
gradient
centrifug
pbmc
suspend
rpmi
medium
gibco
usa
contain
fetal
calf
serum
gibco
usa
pbmc
aliquot
well
tissu
cultur
plate
densiti
cell
per
well
stimul
one
follow
agent
phytohemagglutinin
pha
sigmaaldrich
usa
antibodi
bender
medsystem
candida
antigen
greer
laboratori
usa
purifi
protein
deriv
ppd
csl
limit
australia
cultur
puls
h
h
thymidin
per
well
assess
mitogenantigeninduc
prolifer
thymidin
uptak
dna
determin
h
later
quantit
immunoglobulin
igm
igg
iga
serum
perform
rate
nephelometri
use
beckman
specif
protein
analyz
beckman
instrument
inc
ca
serum
level
igg
antibodi
tetanu
toxoid
tt
diphtheria
toxoid
dt
haemophilu
influenza
type
b
capsular
polysaccharid
hib
measur
use
commerci
elisa
kit
bind
site
usa
antibodi
concentr
deriv
standard
calibr
curv
report
iuml
antitt
antidt
mgl
antipcp
antihib
total
patient
dna
recombin
defect
male
femal
famili
present
report
repres
patient
pid
patient
combin
tand
bcell
immunodefici
regist
knpidr
distribut
patient
follow
defici
defici
defici
patient
except
sibl
born
consanguin
parent
detail
clinic
present
shown
tabl
base
case
definit
develop
primari
immun
defici
treatment
consortium
pidtc
patient
present
scid
omenn
syndrom
os
leaki
scid
cid
granuloma
andor
autoimmun
cidgai
five
patient
screen
flowcytometri
diagnos
earli
life
famili
histori
diseas
patient
diagnos
due
typic
os
featur
infecti
manifest
common
affect
major
patient
follow
bacteri
patient
viral
patient
fungal
patient
nine
patient
receiv
bcg
vaccin
birth
one
develop
local
bcgiti
time
engraft
hematopoiet
stem
cell
transplant
hsct
patient
four
patient
autoimmun
diseas
initi
manifest
detail
immunolog
evalu
shown
tabl
except
patient
os
patient
cidgai
other
cell
lymphopenia
time
diagnosi
mean
cell
count
scid
group
higher
group
cidgai
patient
present
initi
b
phenotyp
reevalu
age
year
show
cell
lymphopenia
repeat
immunolog
test
age
year
show
progress
tcell
lymphopenia
predominantli
activ
phenotyp
nearli
absent
recent
thymic
emigr
two
patient
present
leaki
scid
cell
count
cellul
respect
patient
b
cell
lymphopenia
eighteen
patient
test
lymphocyt
prolifer
use
pha
absent
significantli
decreas
respons
except
patient
cidgai
respons
control
igg
serum
level
test
patient
found
low
normal
patient
may
reflect
matern
origin
ten
patient
test
antibodi
respons
previou
vaccin
good
respons
fifteen
patient
diagnos
target
sanger
sequenc
patient
diagnos
whole
exom
sequenc
patient
diagnos
whole
genom
sequenc
patient
diagnos
target
nextgener
sequenc
detail
mutat
associ
clinic
phenotyp
shown
tabl
patient
treat
intraven
immunoglobulin
replac
prophylact
antibiot
trimethoprimsulfamethoxazol
eight
patient
scid
os
receiv
hematopoiet
stem
cell
transplant
hsct
tabl
median
age
hsct
month
month
median
time
diagnosi
hsct
month
month
hsct
match
relat
donor
v
j
recombin
defect
due
mutat
import
caus
autosom
recess
cid
kuwait
incid
consanguin
rel
high
defect
account
signific
proport
patient
suffer
combin
tand
bcell
immunodefici
sinc
newborn
screen
scid
appli
kuwait
like
signific
number
patient
cid
deceas
diagnosi
mani
patient
less
sever
phenotyp
misdiagnos
frequenc
mutat
patient
combin
tand
bcell
immunodefici
current
studi
similar
unit
state
netherland
much
less
compar
greec
serbia
common
founder
gene
defect
like
patient
homozyg
missens
mutat
led
convers
thymidin
adenin
posit
cdna
na
caus
chang
leucin
l
glutamin
q
posit
dimer
dna
bind
domain
protein
mutat
predict
affect
dimer
dnabind
abil
complex
associ
os
shown
decreas
enzymat
activ
patient
similar
patient
describ
literatur
featur
os
patient
suffer
scid
highlight
heterogen
clinic
os
omenn
syndrom
scid
sever
combin
immunodefici
cidgai
cid
granuloma
andor
autoimmun
manifest
associ
mutat
like
stem
stochast
natur
v
j
recombin
process
compound
environment
factor
patient
homozyg
missens
mutat
led
convers
cytidin
c
posit
cdna
caus
chang
arginin
r
tryptophan
w
posit
residu
locat
nonamerbind
domain
protein
mutat
abolish
protein
activ
alreadi
describ
three
patient
os
patient
suffer
scid
due
mutat
patient
homozyg
mutat
led
convers
na
g
posit
cdna
na
caus
chang
r
q
posit
within
homeodomain
region
homozyg
form
alreadi
associ
scid
heterozyg
form
termin
translat
mutat
allel
associ
os
patient
suffer
cid
granuloma
andor
autoimmun
provid
evid
vast
heterogen
clinic
manifest
associ
mutat
patient
homozyg
missens
mutat
led
convers
guanin
g
c
posit
cdna
nc
caus
chang
glycin
g
alanin
posit
core
region
interfac
interact
domain
describ
previous
patient
present
milder
diseas
phenotyp
patient
suffer
cidgai
patient
diagnos
leaki
scid
contrari
mutat
valin
v
associ
scid
os
shown
abolish
activ
complex
patient
homozyg
missens
mutat
lead
convers
g
posit
cdna
c
result
chang
glycin
arginin
posit
domain
mutat
previous
report
mutat
glutam
associ
scid
signific
reduc
dna
repair
activ
likewis
patient
scid
phenotyp
pneumocysti
jiroveci
infect
patient
homozyg
frameshift
mutat
lead
prematur
stop
codon
posit
residu
domain
mutat
previous
report
prematur
stop
codon
posit
found
patient
scid
patient
also
scid
notabl
enteroviremia
cmv
mening
patient
compound
heterozyg
delet
exon
exon
encod
domain
exon
encod
part
domain
delet
exon
previous
report
homozyg
delet
exon
associ
scid
leaki
scid
autoimmun
cytopenia
patient
os
patient
scid
thu
demonstr
similar
phenotyp
patient
delet
exon
patient
homozyg
missens
mutat
result
convers
g
posit
cdna
na
result
chang
glycin
glutam
posit
domain
mutat
previous
report
mutat
earli
domain
report
caus
scid
os
similarli
patient
leaki
scid
character
abscess
infect
pseudomona
candida
albican
overal
outcom
present
cohort
disappoint
death
occur
patient
despit
fact
hsct
current
avail
cur
treatment
defect
patient
receiv
treatment
sinc
avail
kuwait
children
furthermor
patient
treat
hsct
surviv
procedur
well
known
hsct
cid
age
month
result
superior
outcom
median
age
hsct
cohort
month
month
compar
month
patient
treat
unit
state
median
time
diagnosi
hsct
cohort
month
month
compar
b
month
unit
state
b
month
netherland
delay
due
arrang
need
transfer
patient
center
outsid
kuwait
result
increas
occurr
infect
tissu
damag
known
neg
affect
hsct
outcom
schuetz
et
al
studi
complic
transplant
ragand
artemisdefici
patient
show
latter
group
significantli
higher
occurr
infect
longterm
followup
also
poor
growth
abnorm
dental
develop
endocrin
late
effect
especi
associ
use
alkyl
agent
fact
document
peculiar
hsct
patient
v
j
recombin
defect
peculiar
understood
larg
number
patient
studi
intern
collabor
due
rel
rariti
defect
conclus
present
molecular
character
clinic
immunolog
present
outcom
patient
v
j
recombin
defect
regist
knpidr
gener
pediatrician
awar
wide
spectrum
cid
sinc
earli
diagnosi
treatment
associ
better
outcom
given
rel
rariti
highlight
need
intern
collabor
collect
data
hsct
outcom
differ
genet
defect
caus
cid
